Study guide
5.3 Electrolyte Imbalances & Acid-Base Disorders
MRCPI in General Medicine Part I Written
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Strategy & Foundation
1.1 MRCPI Part I Format, Scoring & Standard-Setting 1.2 RCPI BST Curriculum & Single-Best-Answer Exam Strategy
2 Chapter 2: Cardiology & Vascular Medicine
2.1 Acute Coronary Syndromes & Stable Angina 2.2 Tachyarrhythmias, Bradyarrhythmias & Channelopathies 2.3 Heart Failure & Valvular Heart Disease 2.4 Hypertension, Vascular & Pericardial Diseases
3 Chapter 3: Respiratory Medicine
3.1 Asthma, COPD & Airway Diseases 3.2 Pneumonia, Tuberculosis & Respiratory Infections 3.3 Interstitial Lung Disease & Pleural Disorders 3.4 Pulmonary Embolism, Pulmonary Hypertension & Sleep Apnoea
4 Chapter 4: Gastroenterology & Hepatology
4.1 Upper & Lower GI Disorders & Inflammatory Bowel Disease 4.2 Acute & Chronic Liver Disease 4.3 Pancreatitis, Biliary Tract & GI Bleeding 4.4 Malabsorption, GI Motility & Clinical Nutrition
5 Chapter 5: Nephrology & Acid-Base Disorders
5.1 Acute Kidney Injury & Glomerular Diseases 5.2 Chronic Kidney Disease & Renal Replacement Therapy 5.3 Electrolyte Imbalances & Acid-Base Disorders
6 Chapter 6: Endocrinology & Diabetes
6.1 Diabetes Mellitus & Metabolic Complications 6.2 Thyroid & Calcium Disorders 6.3 Adrenal, Pituitary & Endocrine Syndromes
7 Chapter 7: Rheumatology & Clinical Immunology
7.1 Inflammatory Arthritides 7.2 Systemic Autoimmune & Vasculitic Diseases 7.3 Metabolic Bone Disease & Clinical Immunology
8 Chapter 8: Haematology & Medical Oncology
8.1 Anaemias, Haemostasis & Thrombosis 8.2 Leukaemias, Lymphomas & Plasma Cell Disorders 8.3 Medical Oncology & Oncological Emergencies
9 Chapter 9: Neurology & Dermatology
9.1 Stroke & Cerebrovascular Diseases 9.2 Epilepsy, Headache & Movement Disorders 9.3 Neuromuscular & Peripheral Nerve Disorders 9.4 Cutaneous Manifestations of Systemic Disease
10 Chapter 10: Acute Medicine, Critical Care & Geriatrics
10.1 Acute Poisoning & Toxidromes 10.2 Sepsis, Shock & Resuscitation 10.3 Geriatric Syndromes, Frailty & Comprehensive Care
11 Chapter 11: Clinical Pharmacology & Therapeutics
11.1 Pharmacokinetics & Pharmacodynamics 11.2 High-Risk Drug Classes & Prescribing Safety 11.3 Adverse Drug Reactions & Drug Safety
12 Chapter 12: Basic Sciences, Biostatistics & Clinical Ethics
12.1 Applied Cardiovascular & Respiratory Physiology 12.2 Clinical Biochemistry, Molecular Genetics & Microbiology 12.3 Biostatistics, Evidence-Based Medicine & Ethics
5.3 Electrolyte Imbalances & Acid-Base Disorders
Key Takeaways Explain This Topic AI
Evaluation of hyponatremia requires measuring serum osmolality and clinical volume status; SIADH is characterized by hypotonic hyponatremia, high urine osmolality (>100 mOsm/kg), urine sodium >30 mmol/L, and euvolemia.
Correcting chronic hyponatremia faster than 8-10 mmol/L in 24 hours risks osmotic demyelination syndrome (central pontine myelinolysis), whereas rapid hypernatremia correction risks cerebral edema.
Severe hyperkalemia (>6.5 mmol/L) or ECG changes (peaked T waves, PR prolongation, wide QRS) require immediate intravenous calcium gluconate (10 mL of 10% solution over 2-5 minutes) for myocardial membrane stabilization.
Winter's formula determines expected respiratory compensation in metabolic acidosis: Expected pCO2 = (1.5 x [HCO3-]) + 8 ± 2 mmHg (or 0.2 x [HCO3-] + 1.1 ± 0.3 kPa); pCO2 above expected indicates co-existing respiratory acidosis.
High Anion Gap Metabolic Acidosis (HAGMA, AG >12 mmol/L) causes are remembered by GOLD MARK (Glycols, Oxoproline, L-lactate, D-lactate, Methanol, Aspirin, Renal failure, Ketoacidosis); a Delta-Delta ratio <0.8 reveals a concurrent Normal Anion Gap Metabolic Acidosis.
Last updated: July 2026
Electrolyte Imbalances & Acid-Base Disorders
Electrolyte abnormalities and acid-base disorders are among the most frequent acute clinical presentations in internal medicine. Systematic diagnostic algorithms based on physiological principles are necessary to prevent catastrophic management errors.
Disorders of Sodium & Water Balance
Sodium concentration reflects water balance , not total body sodium content.
1. Hyponatremia Algorithm
Step 1: Confirm Hypotonic Hyponatremia : Check measured serum osmolality. If normal ( 280 – 295 mOsm/kg 280\text{--}295\,\text{mOsm/kg} 280 – 295 mOsm/kg ), suspect pseudohyponatremia (severe hyperlipidemia or hyperproteinemia). If elevated ( > 295 mOsm/kg > 295\,\text{mOsm/kg} > 295 mOsm/kg ), suspect hyperglycemia (corrected Na + = measured Na + + 0.3 × [ Glucose − 5.5 mmol/L ] \text{Na}^+ = \text{measured }\text{Na}^+ + 0.3 \times [\text{Glucose} - 5.5\,\text{mmol/L}] Na + = measured Na + + 0.3 × [ Glucose − 5.5 mmol/L ] ).
Step 2: Assess Volume Status :
Hypovolemic : Dehydration, vomiting/diarrhea (Urine Na + < 20 mmol/L \text{Na}^+ < 20\,\text{mmol/L} Na + < 20 mmol/L ), or renal losses / diuretics (Urine Na + > 20 mmol/L \text{Na}^+ > 20\,\text{mmol/L} Na + > 20 mmol/L ).
Euvolemic : Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH), secondary adrenal insufficiency, severe hypothyroidism, primary polydipsia.
Hypervolemic : Congestive heart failure, liver cirrhosis, nephrotic syndrome (Urine Na + < 20 mmol/L \text{Na}^+ < 20\,\text{mmol/L} Na + < 20 mmol/L ).
Diagnostic Criteria for SIADH
Hypotonic hyponatremia (Serum osmolality < 275 mOsm/kg < 275\,\text{mOsm/kg} < 275 mOsm/kg ).
Inappropriately concentrated urine (Urine osmolality > 100 mOsm/kg > 100\,\text{mOsm/kg} > 100 mOsm/kg ).
High urine sodium concentration (Urine Na + > 30 mmol/L \text{Na}^+ > 30\,\text{mmol/L} Na + > 30 mmol/L ) despite normal salt and water intake.
Euvolemic clinical examination (no edema, no orthostatic hypotension).
Normal thyroid, adrenal, and renal function.
Treatment & Safety Limits
Severe Symptomatic Hyponatremia (seizures, coma, confusion): Administer 150 mL 150\,\text{mL} 150 mL of 3 % 3\% 3% hypertonic saline IV over 20 minutes; repeat if necessary to raise serum Na + \text{Na}^+ Na + by 4 – 6 mmol/L 4\text{--}6\,\text{mmol/L} 4 – 6 mmol/L acutely.
Correction Limit : Never exceed a rise of 8 – 10 mmol/L 8\text{--}10\,\text{mmol/L} 8 – 10 mmol/L in 24 hours ( < 18 mmol/L < 18\,\text{mmol/L} < 18 mmol/L in 48 hours). Overly rapid correction leads to Osmotic Demyelination Syndrome (Central Pontine Myelinolysis) , manifesting with spastic quadriparesis, pseudobulbar palsy, and locked-in syndrome.
Disorders of Potassium Balance
Potassium is primarily an intracellular cation ( 98 % 98\% 98% intracellular, [ K + ] ≈ 140 mmol/L [\text{K}^+] \approx 140\,\text{mmol/L} [ K + ] ≈ 140 mmol/L ). Small shifts between intracellular and extracellular compartments produce drastic changes in serum concentration.
Hyperkalemia Management Protocol
Severe hyperkalemia ( [ K + ] > 6.5 mmol/L [\text{K}^+] > 6.5\,\text{mmol/L} [ K + ] > 6.5 mmol/L ) or hyperkalemia accompanied by ECG changes is a medical emergency requiring rapid sequential treatment.
Progression of ECG Changes Potassium Level Management Action
Peaked T waves (tall, narrow, symmetric) 5.5 – 6.5 mmol/L 5.5\text{--}6.5\,\text{mmol/L} 5.5 – 6.5 mmol/L Monitor ECG, initiate potassium-shifting therapies
PR prolongation & P wave flattening 6.5 – 7.0 mmol/L 6.5\text{--}7.0\,\text{mmol/L} 6.5 – 7.0 mmol/L Immediate IV Calcium + Intracellular shifting
QRS widening & bundle branch blocks 7.0 – 8.0 mmol/L 7.0\text{--}8.0\,\text{mmol/L} 7.0 – 8.0 mmol/L Immediate IV Calcium + Intracellular shifting + Elimination
Sine wave pattern, VF, or Asystole > 8.0 mmol/L > 8.0\,\text{mmol/L} > 8.0 mmol/L Immediate IV Calcium + CPR / Emergency Hemodialysis
Three-Step Emergency Treatment:
Myocardial Membrane Stabilization (Acts within 1–3 minutes; duration 30–60 minutes):
Calcium Gluconate 10% : 10 mL 10\,\text{mL} 10 mL IV over 2–5 minutes (or Calcium Chloride 10 % 10 mL 10\%\,10\,\text{mL} 10% 10 mL via central access). Stabilizes resting membrane potential without lowering serum potassium.
Intracellular Potassium Shifting (Acts within 15–30 minutes):
Insulin & Dextrose : 10 units Actrapid insulin in 50 mL 50\,\text{mL} 50 mL of 50 % 50\% 50% Dextrose IV. Drives K + \text{K}^+ K + into cells via Na + / K + -ATPase \text{Na}^+/\text{K}^+\text{-ATPase} Na + / K + -ATPase stimulation.
Nebulized Salbutamol : 10 – 20 mg 10\text{--}20\,\text{mg} 10 – 20 mg nebulized. β 2 \beta_2 β 2 -agonist action stimulates Na + / K + -ATPase \text{Na}^+/\text{K}^+\text{-ATPase} Na + / K + -ATPase .
Intravenous Sodium Bicarbonate : 8.4 % 50 – 100 mL 8.4\%\,50\text{--}100\,\text{mL} 8.4% 50 – 100 mL IV (only if concomitant metabolic acidosis).
Potassium Elimination from the Body :
Cation Exchange Resins / Binders : Sodium Zirconium Cyclosilicate (Lokelma) or Patiromer.
Loop Diuretics : Furosemide 40 – 80 mg 40\text{--}80\,\text{mg} 40 – 80 mg IV (if renal function is preserved).
Hemodialysis : Definitive removal in renal failure.
Systematic Approach to Acid-Base Disorders
Arterial Blood Gas (ABG) analysis follows a structured four-step procedure:
Step 1 : Check pH (Acidemia < 7.35 <7.35 < 7.35 vs. Alkalemia > 7.45 >7.45 > 7.45 ).
Step 2 : Identify Primary Process (Change in HCO 3 − \text{HCO}_3^- HCO 3 − vs. pCO 2 \text{pCO}_2 pCO 2 ).
Step 3 : Calculate Compensation (Winter's Formula for Metabolic Acidosis).
Step 4 : Calculate Serum Anion Gap = [ Na + ] − ( [ Cl − ] + [ HCO 3 − ] ) = [\text{Na}^+] - ([\text{Cl}^-] + [\text{HCO}_3^-]) = [ Na + ] − ([ Cl − ] + [ HCO 3 − ]) .
Normal Reference Ranges (ABG):
pH \text{pH} pH : 7.35 – 7.45 7.35\text{--}7.45 7.35 – 7.45
pCO 2 \text{pCO}_2 pCO 2 : 4.7 – 6.0 kPa 4.7\text{--}6.0\,\text{kPa} 4.7 – 6.0 kPa ( 35 – 45 mmHg 35\text{--}45\,\text{mmHg} 35 – 45 mmHg )
HCO 3 − \text{HCO}_3^- HCO 3 − : 22 – 26 mmol/L 22\text{--}26\,\text{mmol/L} 22 – 26 mmol/L
Base Excess \text{Base Excess} Base Excess : − 2 to + 2 mmol/L -2\text{ to }+2\,\text{mmol/L} − 2 to + 2 mmol/L
Metabolic Acidosis & Anion Gap Calculation
Serum Anion Gap ( AG \text{AG} AG ) represents unmeasured anions in plasma: Anion Gap = [ Na + ] − ( [ Cl − ] + [ HCO 3 − ] ) \text{Anion Gap} = [\text{Na}^+] - ([\text{Cl}^-] + [\text{HCO}_3^-]) Anion Gap = [ Na + ] − ([ Cl − ] + [ HCO 3 − ])
Normal Range : 8 – 12 mmol/L 8\text{--}12\,\text{mmol/L} 8 – 12 mmol/L . (Correct for hypoalbuminemia: add 2.5 mmol/L 2.5\,\text{mmol/L} 2.5 mmol/L to AG for every 10 g/L 10\,\text{g/L} 10 g/L drop in serum albumin below 40 g/L 40\,\text{g/L} 40 g/L ).
Differential Diagnosis of Metabolic Acidosis
High Anion Gap ( > 12 mmol/L > 12\,\text{mmol/L} > 12 mmol/L ) ( GOLD MARK ) Normal Anion Gap ( 8 – 12 mmol/L 8\text{--}12\,\text{mmol/L} 8 – 12 mmol/L ) ( Hyperchloremic )
- G lycols (Ethylene glycol, Diethylene glycol) G I bicarbonate loss (Diarrhea, ileostomy, pancreatic fistula)
- O xoproline (Chronic paracetamol use in malnutrition) R enal Tubular Acidosis (Types 1, 2, and 4)
- L -lactate (Sepsis, shock, hypoperfusion) A cetazolamide / Carbonic anhydrase inhibitors
- D -lactate (Short bowel syndrome) N ormal Saline resuscitation (High [ Cl − ] [\text{Cl}^-] [ Cl − ] infusion)
- M ethanol U reterosigmoidostomy
- A spirin / Salicylates
- R enal failure (Uremia - retention of phosphate/sulfate)
- K etoacidosis (Diabetic, Alcoholic, Starvation)
- Winter's Formula for Respiratory Compensation
In metabolic acidosis, expected respiratory compensation ( pCO 2 \text{pCO}_2 pCO 2 ) is calculated using Winter's formula: Expected pCO 2 ( mmHg ) = 1.5 × [ HCO 3 − ] + 8 ± 2 \text{Expected }\text{pCO}_2 (\text{mmHg}) = 1.5 \times [\text{HCO}_3^-] + 8 \pm 2 Expected pCO 2 ( mmHg ) = 1.5 × [ HCO 3 − ] + 8 ± 2 Expected pCO 2 ( kPa ) = 0.2 × [ HCO 3 − ] + 1.1 ± 0.3 \text{Expected }\text{pCO}_2 (\text{kPa}) = 0.2 \times [\text{HCO}_3^-] + 1.1 \pm 0.3 Expected pCO 2 ( kPa ) = 0.2 × [ HCO 3 − ] + 1.1 ± 0.3
If measured pCO 2 > expected pCO 2 \text{pCO}_2 > \text{expected } \text{pCO}_2 pCO 2 > expected pCO 2 : Co-existing Respiratory Acidosis (e.g., respiratory depression, severe asthma/COPD).
If measured pCO 2 < expected pCO 2 \text{pCO}_2 < \text{expected } \text{pCO}_2 pCO 2 < expected pCO 2 : Co-existing Respiratory Alkalosis (e.g., salicylate toxicity, sepsis, pulmonary embolism).
Delta Ratio ( Δ / Δ \Delta / \Delta Δ/Δ ) for Mixed Disorders
In High Anion Gap Metabolic Acidosis, calculate the Delta Ratio: Delta Ratio = Δ Anion Gap Δ HCO 3 − = Calculated AG − 12 24 − Measured HCO 3 − \text{Delta Ratio} = \frac{\Delta \text{Anion Gap}}{\Delta \text{HCO}_3^-} = \frac{\text{Calculated AG} - 12}{24 - \text{Measured } \text{HCO}_3^-} Delta Ratio = Δ HCO 3 − Δ Anion Gap = 24 − Measured HCO 3 − Calculated AG − 12
< 0.8 < 0.8 < 0.8 : Combined High Anion Gap and Normal Anion Gap Metabolic Acidosis (e.g., DKA + Diarrhea).
1.0 – 2.0 1.0\text{--}2.0 1.0 – 2.0 : Uncomplicated High Anion Gap Metabolic Acidosis.
> 2.0 > 2.0 > 2.0 : Combined High Anion Gap Metabolic Acidosis and Metabolic Alkalosis (e.g., DKA + Vomiting) or pre-existing chronic respiratory acidosis.
Renal Tubular Acidosis (RTA) Differentiation
Feature Type 1 RTA (Distal) Type 2 RTA (Proximal) Type 4 RTA (Hyperkalemic)
Primary Defect Impaired distal H + \text{H}^+ H + secretion by intercalated cells Impaired proximal HCO 3 − \text{HCO}_3^- HCO 3 − reabsorption Aldosterone deficiency or resistance
Urine pH Inability to acidify urine: > 5.5 > 5.5 > 5.5 Variable: < 5.5 < 5.5 < 5.5 once systemic threshold reached Systemic acidification intact: < 5.5 < 5.5 < 5.5
Serum Potassium Hypokalemia (low [ K + ] [\text{K}^+] [ K + ] ) Hypokalemia (low [ K + ] [\text{K}^+] [ K + ] ) Hyperkalemia (high [ K + ] [\text{K}^+] [ K + ] )
Complications Nephrocalcinosis, calcium phosphate renal stones Fanconi syndrome (glucosuria, phosphaturic rickets, aminoaciduria) Hypoaldosteronism, diabetic nephropathy, NSAIDs
Treatment Oral sodium bicarbonate High-dose HCO 3 − \text{HCO}_3^- HCO 3 − + thiazide diuretic Fludrocortisone, dietary potassium restriction